Vivos Therapeutics, Inc.
VVOS- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001716166
No open-market purchases or sales by Vivos Therapeutics, Inc. insiders were filed in the last 90 days; 22 institutions reported holding it in 13F filings for Q2 2026, worth $242.7K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Vivos Therapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −10 vs. Q3 2023
- Shares held
- 257.0K
- +78.0K (+43.6%) vs. Q3 2023Converted for a 1-for-25 split
- Total value
- $3.12M
- +$2.26M (+262.4%) vs. Q3 2023
- New holders
- 4
- 6 more added
- Sold out
- 14
- 3 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VVOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 22 | $242.7K |
| Q1 2026 | 25 | $2.15M |
| Q4 2025 | 20 | $1.34M |
| Q3 2025 | 23 | $2.13M |
| Q2 2025 | 19 | $1.27M |
| Q1 2025 | 21 | $1.00M |
| Q4 2024 | 20 | $2.00M |
| Q3 2024 | 23 | $630.7K |
| Q2 2024 | 19 | $433.8K |
| Q1 2024 | 16 | $646.8K |
| Q4 2023 | 18 | $3.12M |
| Q3 2023 | 28 | $860.6K |
| Q2 2023 | 31 | $2.39M |
| Q1 2023 | 30 | $1.71M |
| Q4 2022 | 27 | $629.7K |
| Q3 2022 | 30 | $1.38M |
| Q2 2022 | 28 | $2.82M |
| Q1 2022 | 28 | $6.66M |
| Q4 2021 | 29 | $5.02M |
| Q3 2021 | 37 | $9.14M |
| Q2 2021 | 29 | $11.7M |
| Q1 2021 | 18 | $5.45M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Vivos Therapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cutler Group LP | 12 | $0 | 0.00% | −232−95.1% | ReducedConverted for a 1-for-25 split |
| Royal Bank of Canada | 7 | $0 | 0.00% | −11−60.1% | ReducedConverted for a 1-for-25 split |
| Wells Fargo & Company | 7 | $87 | 0.00% | +1+11.5% | AddedConverted for a 1-for-25 split |
| Steward Partners Investment Advisory, LLC | 8 | $100 | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Global Retirement Partners, LLC | 23 | $165 | 0.00% | +0+0.9% | AddedConverted for a 1-for-25 split |
| Credit Agricole S A | 2,365 | $294 | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Kozak & Associates, Inc. | 49 | $351 | 0.00% | +1+1.7% | AddedConverted for a 1-for-25 split |
| BlackRock Inc. | 42 | $522 | 0.00% | +1+1.3% | AddedConverted for a 1-for-25 split |
| Morgan Stanley | 67 | $833 | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Ronald Blue Trust, Inc. | 4,000 | $1.00K | 0.00% | +3,840+2,400.0% | AddedConverted for a 1-for-25 split |
| Group One Trading, L.P. | 388 | $4.83K | 0.00% | +379+4,454.0% | AddedConverted for a 1-for-25 split |
| Signaturefd, LLC | 547 | $6.80K | 0.00% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Newbridge Financial Services Group, Inc. | 1,295 | $16.1K | 0.01% | +1,295 | New |
| Tower Research Capital LLC (TRC) | 1,718 | $21.4K | 0.00% | +1,718 | New |
| Vanguard Group Inc | 10,579 | $131.6K | 0.00% | −14,022−57.0% | ReducedConverted for a 1-for-25 split |
| Schonfeld Strategic Advisors LLC | 50,100 | $623.2K | 0.01% | +50,100 | New |
| Armistice Capital, LLC | 57,000 | $709.1K | 0.02% | +57,000 | New |
| Strategic Wealth Designers | 128,789 | $1.60M | 0.24% | 00.0% | UnchangedConverted for a 1-for-25 split |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −8,078−100.0% | Sold outConverted for a 1-for-25 split |
| HRT Financial LP | 0 | $0 | 0.00% | −3,508−100.0% | Sold outConverted for a 1-for-25 split |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −2,133−100.0% | Sold outConverted for a 1-for-25 split |
| State Street Corp | 0 | $0 | 0.00% | −1,826−100.0% | Sold outConverted for a 1-for-25 split |
| Apexium Financial, LP | 0 | $0 | 0.00% | −1,627−100.0% | Sold outConverted for a 1-for-25 split |
| LPL Financial LLC | 0 | $0 | 0.00% | −1,419−100.0% | Sold outConverted for a 1-for-25 split |
| Northern Trust Corp | 0 | $0 | 0.00% | −1,186−100.0% | Sold outConverted for a 1-for-25 split |
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −746−100.0% | Sold outConverted for a 1-for-25 split |
| Perkins Capital Management Inc | 0 | $0 | 0.00% | −600−100.0% | Sold outConverted for a 1-for-25 split |
| Lincoln National Corp | 0 | $0 | 0.00% | −593−100.0% | Sold outConverted for a 1-for-25 split |
| UBS Group AG | 0 | $0 | 0.00% | −370−100.0% | Sold outConverted for a 1-for-25 split |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −8−100.0% | Sold outConverted for a 1-for-25 split |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-25 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −7−100.0% | Sold outConverted for a 1-for-25 split |